Related Experiment Videos
Clinical epidemiology: diagnostic and prognostic tests
1Intramural Research Program, National Institute of Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA. wardm1@mail.nih.gov
Current Opinion in Rheumatology
|February 25, 2003
Summary
Diagnosing rheumatoid arthritis (RA) can be improved with antifilaggrin antibodies, though sensitivity in early RA needs more research. Advanced imaging and genetic markers also aid in RA prognosis and diagnosis.
Area of Science:
- Rheumatology
- Immunology
- Medical Diagnostics
Background:
- Diagnostic and prognostic tests for rheumatoid arthritis (RA) are under active investigation.
- Serological tests and advanced imaging techniques are key areas of focus.
Purpose of the Study:
- To review recent advancements in diagnostic and prognostic tests for rheumatoid arthritis.
- To highlight the utility and limitations of specific biomarkers and imaging modalities.
Main Methods:
- Review of recent studies on serological tests, including antifilaggrin antibodies.
- Evaluation of magnetic resonance imaging (MRI) and ultrasound for detecting RA-related changes.
- Analysis of genetic associations, specifically the human leukocyte antigen DRB1 shared epitope.
Main Results:
- Antifilaggrin antibodies show high specificity for RA diagnosis, but sensitivity in early RA requires further clarification.
- MRI and ultrasound are valuable for visualizing synovitis and erosions in RA.
- The human leukocyte antigen DRB1 shared epitope is linked to poorer radiographic outcomes in RA patients.
Conclusions:
- Current diagnostic approaches for RA involve a combination of serological markers and imaging.
- Further research is needed to optimize the sensitivity of antifilaggrin antibodies in early RA.
- Interlaboratory variability in autoantibody testing and potential overuse of certain tests warrant attention.